BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17689077)

  • 21. Chondramide C: synthesis, configurational assignment, and structure-activity relationship studies.
    Eggert U; Diestel R; Sasse F; Jansen R; Kunze B; Kalesse M
    Angew Chem Int Ed Engl; 2008; 47(34):6478-82. PubMed ID: 18624309
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and cytotoxicity studies of new cryptophycin analogues.
    Liu WL; Zhang JC; Jiang FQ; Fu L
    Arch Pharm (Weinheim); 2009 Oct; 342(10):577-83. PubMed ID: 19714674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor activity of an antibiotic peptide derived from apoprotein E.
    Kojima T; Fujimitsu Y; Kojima H
    In Vivo; 2005; 19(1):261-4. PubMed ID: 15796184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aranciamycin analogs generated by combinatorial biosynthesis show improved antitumor activity.
    Luzhetskyy A; Hoffmann J; Pelzer S; Wohlert SE; Vente A; Bechthold A
    Appl Microbiol Biotechnol; 2008 Aug; 80(1):15-9. PubMed ID: 18553079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationship studies of curcumin analogues.
    Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
    Lyu MA; Kurzrock R; Rosenblum MG
    Biochem Pharmacol; 2008 Feb; 75(4):836-46. PubMed ID: 18082672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
    Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
    Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of chalcone derivatives on steroidal framework and their anticancer activities.
    Saxena HO; Faridi U; Kumar JK; Luqman S; Darokar MP; Shanker K; Chanotiya CS; Gupta MM; Negi AS
    Steroids; 2007 Nov; 72(13):892-900. PubMed ID: 17850837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of c7-demethyl largazole analogues.
    Chen F; Gao AH; Li J; Nan FJ
    ChemMedChem; 2009 Aug; 4(8):1269-72. PubMed ID: 19431162
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
    Banti I; Nencetti S; Orlandini E; Lapucci A; Breschi MC; Fogli S
    J Pharm Pharmacol; 2009 Aug; 61(8):1057-66. PubMed ID: 19703350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tessaric acid derivatives induce G2/M cell cycle arrest in human solid tumor cell lines.
    León LG; Donadel OJ; Tonn CE; Padrón JM
    Bioorg Med Chem; 2009 Sep; 17(17):6251-6. PubMed ID: 19664930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET imaging of Hsp90 expression in pancreatic cancer using a new
    Wang X; Zhang J; Wu H; Li Y; Conti PS; Chen K
    Amino Acids; 2018 Jul; 50(7):897-907. PubMed ID: 29691700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and structure-activity relationships of antiproliferative 1,3-disubstituted urea derivatives.
    Li HQ; Zhu TT; Yan T; Luo Y; Zhu HL
    Eur J Med Chem; 2009 Feb; 44(2):453-9. PubMed ID: 18514972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
    Kumar D; Patel G; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces.
    Miller ED; Kauffman CA; Jensen PR; Fenical W
    J Org Chem; 2007 Jan; 72(2):323-30. PubMed ID: 17221946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
    Xie F; Zhao H; Zhao L; Lou L; Hu Y
    Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.